1-8 of 8
Steven M. Larson
Close
Sort by
Journal Articles

Phase I Trial of the Targeted Alpha-Particle Nano-Generator Actinium-225 ( 225 Ac)-Lintuzumab (Anti-CD33; HuM195) in Acute Myeloid Leukemia (AML)

Joseph G. Jurcic, MD, Todd L. Rosenblat, MD, Michael R. McDevitt, PhD, Neeta Pandit-Taskar, MD, Jorge A. Carrasquillo, MD, Suzanne M. Chanel, RN, Kevin Zikaras, BS, Mark G. Frattini, MD, PhD, Peter G. Maslak, M.D., Dragan Cicic, MD, Steven M. Larson, MD, David A. Scheinberg, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 768.
https://doi.org/10.1182/blood.V118.21.768.768
Published: 2011
Journal Articles

Sequential Cytarabine and Alpha-Particle Immunotherapy with Bismuth-213 ( 213 Bi)-Labeled-HuM195 (Lintuzumab) for Acute Myeloid Leukemia (AML)

Todd Rosenblat, MD, MS, Michael R. McDevitt, PhD, Deborah A. Mulford, MD, Neeta Pandit-Taskar, MD, Mark A. Weiss, MD, Mark L. Heaney, MD, PhD, Suzanne Chanel, RN, Alfred Morgenstern, PhD, Steven M. Larson, MD, David A. Scheinberg, MD, PhD, Joseph G. Jurcic, MD
Journal: Blood
Blood (2008) 112 (11): 2983.
https://doi.org/10.1182/blood.V112.11.2983.2983
Published: 2008
Journal Articles

Cdk4/6 Inhibitor PD 0332991 Demonstrates Cell Cycle Inhibition Via FLT-PET Imaging and Tissue Analysis in Patients with Recurrent Mantle Cell Lymphoma

John P. Leonard, MD, Ann LaCasce, MD, Mitchell R Smith, MD, PhD, Ariela Noy, MD, Jeffrey T Yap, PhD, Annick D Van den Abbeele, MD, Jian Q Yu, MD, FRCPC, Selina Chen-Kiang, PhD, Scott A Ely, MD, PhD, Shankar Vallabhajosula, PhD, Lucian R Chirieac, MD, Steven M Larson, MD, Geoffrey I Shapiro, MD, PhD, Heiko Schoder
Journal: Blood
Blood (2008) 112 (11): 264.
https://doi.org/10.1182/blood.V112.11.264.264
Published: 2008
Journal Articles

The Novel Human Ph + Acute Lymphoblastic Leukemia Cell Line PhALL3.1 Is Amenable to Retroviral Gene Transfer and Mimics Human Disease Progression in SCID-Beige Mice

Mark G. Frattini, MD, PhD, Elmer Santos, MD, PhD, Mark Lawrence Heaney, MD, PhD, Peter Maslak, MD, Suresh C Jhanwar, PhD, Steven M Larson, MD, Elisa De Stanchina, PhD, Bayard Clarkson, MD, Renier J. Brentjens, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4875.
https://doi.org/10.1182/blood.V112.11.4875.4875
Published: 2008
Journal Articles

Phase I Trial of the Targeted Alpha-Particle Nano-Generator Actinium-225 ( 225 Ac)-HuM195 (Anti-CD33) in Acute Myeloid Leukemia (AML).

Todd L. Rosenblat, MD, Michael R. McDevitt, PhD, Neeta Pandit-Taskar, MD, Jorge A. Carrasquillo, MD, Suzanne Chanel, RN, Mark G. Frattini, MD, PhD, Steven M. Larson, MD, David A. Scheinberg, MD, PhD, Joseph G. Jurcic, MD
Journal: Blood
Blood (2007) 110 (11): 910.
https://doi.org/10.1182/blood.V110.11.910.910
Published: 2007
Journal Articles

Sequential Therapy with Cytarabine and Bismuth-213 ( 213 Bi)-Labeled-HuM195 (Anti-CD33) for Acute Myeloid Leukemia (AML).

Deborah A. Mulford, M.D., Neeta Pandit-Taskar, M.D., Michael R. McDevitt, Ph.D., Ronald D. Finn, Ph.D., Mark A. Weiss, M.D., Christos Apostolidis, Ph.D., Alfred Morgenstern, Ph.D., Chaitanya R. Divgi, M.D., Steven M. Larson, Ph.D., David A. Scheinberg, M.D., Ph.D., Joseph G. Jurcic, M.D.
Journal: Blood
Blood (2004) 104 (11): 1790.
https://doi.org/10.1182/blood.V104.11.1790.1790
Published: 2004
Journal Articles

Targeted α particle immunotherapy for myeloid leukemia

Clinical Trials & Observations
Joseph G. Jurcic, Steven M. Larson, George Sgouros, Michael R. McDevitt, Ronald D. Finn, Chaitanya R. Divgi, Åse M. Ballangrud, Klaus A. Hamacher, Dangshe Ma, John L. Humm, Martin W. Brechbiel, Roger Molinet, David A. Scheinberg
Journal: Blood
Blood (2002) 100 (4): 1233–1239.
https://doi.org/10.1182/blood.V100.4.1233.h81602001233_1233_1239
Published: 2002
Journal Articles

Long-term Effects of Local Irradiation of the Marrow on Erythron and Red Cell Function

WIL B. NELP, M.D., MAHENDRA N. GOHIL, M.D., STEVEN M. LARSON, M.D., RAE ELLEN BOWER, B.S.
Journal: Blood
Blood (1970) 36 (5): 617–622.
https://doi.org/10.1182/blood.V36.5.617.617
Published: 1970